Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John E. Kao sold 180,000 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, July 10th. The stock was sold at an average price of $13.41, for a total value of $2,413,800.00. Following the transaction, the chief executive officer directly owned 1,553,100 shares in the company, valued at approximately $20,827,071. This trade represents a 10.39% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Alignment Healthcare Price Performance
NASDAQ:ALHC traded up $0.03 during trading hours on Monday, hitting $13.40. The company's stock had a trading volume of 3,336,242 shares, compared to its average volume of 2,234,630. Alignment Healthcare, Inc. has a 52-week low of $7.92 and a 52-week high of $21.06. The company has a debt-to-equity ratio of 2.95, a quick ratio of 1.69 and a current ratio of 1.69. The business's 50-day moving average is $14.61 and its two-hundred day moving average is $15.31. The company has a market capitalization of $2.65 billion, a PE ratio of -27.92 and a beta of 1.16.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.12) by $0.07. The business had revenue of $926.93 million during the quarter, compared to the consensus estimate of $889.83 million. Alignment Healthcare had a negative net margin of 3.02% and a negative return on equity of 80.49%. The business's revenue was up 47.5% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.25) EPS. As a group, research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on the stock. UBS Group increased their target price on shares of Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a research note on Friday, May 2nd. Robert W. Baird increased their price objective on Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. Stifel Nicolaus boosted their target price on Alignment Healthcare from $18.00 to $23.00 and gave the company a "buy" rating in a report on Tuesday, April 8th. Finally, Stephens raised Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $17.17.
Get Our Latest Analysis on Alignment Healthcare
Institutional Investors Weigh In On Alignment Healthcare
Several institutional investors have recently modified their holdings of ALHC. MCF Advisors LLC raised its holdings in Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after purchasing an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of Alignment Healthcare in the first quarter valued at $42,000. Amalgamated Bank increased its position in shares of Alignment Healthcare by 21.6% in the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock valued at $65,000 after buying an additional 616 shares in the last quarter. RiverPark Advisors LLC acquired a new position in shares of Alignment Healthcare during the 4th quarter worth $106,000. Finally, Tower Research Capital LLC TRC boosted its position in shares of Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock worth $119,000 after buying an additional 6,286 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.
About Alignment Healthcare
(
Get Free Report)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Further Reading
Before you consider Alignment Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.
While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
